Literature DB >> 2819759

The corticotropin-releasing factor release in rat hypophysial portal blood is mediated by brain catecholamines.

V Guillaume, B Conte-Devolx, A Szafarczyk, F Malaval, N Pares-Herbute, M Grino, G Alonso, I Assenmacher, C Oliver.   

Abstract

In order to study the involvement of the hypothalamic corticotropin-releasing factor (CRF) in catecholamine-induced adrenocorticotropin (ACTH) secretion, we have measured CRF levels in rat hypophysial portal blood (HPB) after the pharmacological destruction of the ventral noradrenergic bundle (VNAB), using 6-hydroxydopamine (6-OHDA) stereotaxically injected into the VNAB. CRF levels in HPB were measured by radioimmunoassay, and the effects of 6-OHDA injection were controlled by the determination of catecholamine concentrations in the total hypothalamus. VNAB lesions induced a dramatic decrease in norepinephrine and epinephrine hypothalamic concentration. The CRF levels in HPB were also significantly reduced. These results suggest that central catecholamines exert a direct stimulatory control on the CRF release and play a major role in stress-induced ACTH secretion.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2819759     DOI: 10.1159/000124811

Source DB:  PubMed          Journal:  Neuroendocrinology        ISSN: 0028-3835            Impact factor:   4.914


  22 in total

1.  Divergent projections of catecholaminergic neurons in the nucleus of the solitary tract to limbic forebrain and medullary autonomic brain regions.

Authors:  Beverly A S Reyes; Elisabeth J Van Bockstaele
Journal:  Brain Res       Date:  2006-09-07       Impact factor: 3.252

2.  Paraventricular nucleus corticotrophin releasing hormone contributes to sympathoexcitation via interaction with neurotransmitters in heart failure.

Authors:  Yu-Ming Kang; Ai-Qun Zhang; Xiu-Fang Zhao; Jeffrey P Cardinale; Carrie Elks; Xi-Mei Cao; Zhen-Wen Zhang; Joseph Francis
Journal:  Basic Res Cardiol       Date:  2011-02-02       Impact factor: 17.165

Review 3.  Central neuroregulation of hypothalamic corticotropin-releasing hormone (CRH-41) secretion.

Authors:  S Tsagarakis; A Grossman
Journal:  J Endocrinol Invest       Date:  1990-10       Impact factor: 4.256

4.  The effects of oral sumatriptan, a 5-HT1 receptor agonist, on circulating ACTH and cortisol concentrations in man.

Authors:  S J Entwisle; P A Fowler; M Thomas; D J Eckland; S Lettis; M York; P S Freedman
Journal:  Br J Clin Pharmacol       Date:  1995-04       Impact factor: 4.335

5.  Catecholamine effects upon rat hypothalamic corticotropin-releasing hormone secretion in vitro.

Authors:  A E Calogero; W T Gallucci; G P Chrousos; P W Gold
Journal:  J Clin Invest       Date:  1988-09       Impact factor: 14.808

6.  Insulin-induced hypoglycemia stimulates corticotropin-releasing factor and arginine vasopressin secretion into hypophysial portal blood of conscious, unrestrained rams.

Authors:  A Caraty; M Grino; A Locatelli; V Guillaume; F Boudouresque; B Conte-Devolx; C Oliver
Journal:  J Clin Invest       Date:  1990-06       Impact factor: 14.808

7.  The involvement of noradrenergic ascending pathways in the stress-induced activation of ACTH and corticosterone secretions is dependent on the nature of stressors.

Authors:  S Gaillet; J Lachuer; F Malaval; I Assenmacher; A Szafarczyk
Journal:  Exp Brain Res       Date:  1991       Impact factor: 1.972

8.  Association of dopaminergic fibers with corticotropin releasing hormone (CRH)-synthesizing neurons in the paraventricular nucleus of the rat hypothalamus.

Authors:  Z Liposits; W K Paull
Journal:  Histochemistry       Date:  1989

9.  Influence of steroids on the hypothalamic corticotropin-releasing factor and preproenkephalin mRNA responses to stress.

Authors:  S L Lightman; W S Young
Journal:  Proc Natl Acad Sci U S A       Date:  1989-06       Impact factor: 11.205

10.  Role of alpha-1-adrenergic receptors in the regulation of corticotropin-releasing hormone mRNA in the paraventricular nucleus of the hypothalamus during stress.

Authors:  A Kiss; G Aguilera
Journal:  Cell Mol Neurobiol       Date:  2000-12       Impact factor: 5.046

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.